AAAAAA
Results:
1-16
|
Results: 16
Authors:
TENERO D
MARTIN D
CHAPELSKY M
ILSON B
BOIKE S
PATTERSON S
KEOGH J
RODRIGUEZ S
JORKASKY D
Citation: D. Tenero et al., EFFECT OF HEPATIC-DISEASE ON THE PHARMACOKINETICS AND PLASMA-PROTEIN BINDING OF EPROSARTAN, Pharmacotherapy, 18(1), 1998, pp. 42-50
Authors:
TENERO D
MARTIN D
ILSON B
JUSHCHYSHYN J
BOIKE S
LUNDBERG D
ZARIFFA N
BOYLE D
JORKASKY D
Citation: D. Tenero et al., PHARMACOKINETICS OF INTRAVENOUSLY AND ORALLY-ADMINISTERED EPROSARTAN IN HEALTHY-MALES - ABSOLUTE BIOAVAILABILITY AND EFFECT OF FOOD, Biopharmaceutics & drug disposition, 19(6), 1998, pp. 351-356
Authors:
DICICCO R
ALLEN A
JORKASKY D
CARR A
FREED M
Citation: R. Dicicco et al., LACK OF PHARMACOKINETIC DRUG-INTERACTION BETWEEN ROSIGLITAZONE (BRL 49653C) AND METFORMIN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 75-75
Authors:
LEVITT B
CHAPELSKY M
BOYLE G
WELLS T
JONES S
JORKASKY D
Citation: B. Levitt et al., SAFETY AND PHARMACOKINETICS (PK) OF NABUMETONE (N) AND 6-MNA IN JUVENILE RHEUMATOID-ARTHRITIS (JRA) PATIENTS AND HEALTHY ADULT MALES FOLLOWING REPEATED ORAL DOSES OF NABUMETONE CHEWABLE TABLETS (NCT), Arthritis and rheumatism, 41(9), 1998, pp. 81-81
Authors:
EVERITT DE
BOIKE SC
PILTZSEYMOUR JR
VANCOEVORDEN R
AUDET P
ZARIFFA N
JORKASKY D
Citation: De. Everitt et al., EFFECT OF INTRAVENOUS FENOLDOPAM ON INTRAOCULAR-PRESSURE IN OCULAR HYPERTENSION, Journal of clinical pharmacology, 37(4), 1997, pp. 312-320
Authors:
LUDERER J
PIERGIES AA
JORKASKY D
SEDMAN A
REELE S
FROEHLICH J
CAVANAUGH J
STEINMAN GL
Citation: J. Luderer et al., CLINICAL-PHARMACOLOGY AND FIRST-TIME-IN-MAN STUDIES - THE FDA LEVELS THE PLAYING FIELD, Journal of clinical pharmacology, 36(3), 1996, pp. 187-188
Authors:
BENINCOSA LJ
THOMPSON KA
EVERITT DE
OLDHAM H
PATTERSON S
JORKASKY D
BAY MK
SCHENKER S
Citation: Lj. Benincosa et al., PHARMACOKINETICS (PK) AND PROTEIN-BINDING (PG) OF EPRISTERIDE (E) IN LIVER-DISEASE PATIENTS (LDP) AND HEALTHY MALE-SUBJECTS (HS), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 52-52
Authors:
TENERO D
ILSON B
BOYLE D
BOIKE S
ZARIFFA N
BROZENA S
FESNIAK H
JORKASKY D
Citation: D. Tenero et al., DOSE-PROPORTIONAL STEREOSELECTIVE KINETICS OF CARVEDILOL IN PATIENTS WITH CHF, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 54-54
Authors:
THOMPSON KA
EVERITT DE
CHAPELSKY M
MILLER AK
HERZYK DJ
JORKASKY D
Citation: Ka. Thompson et al., SAFETY, PHARMACOKINETICS AND ANTIGENICITY OF SINGLE AND REPEAT IM INJECTIONS OF A RESHAPED HUMAN MONOCLONAL-ANTIBODY (RSHZ19) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 61-61
Authors:
EVERITT D
THOMPSON K
DICICCO R
DAVIS C
DEMUTH S
HERZYK DJ
ILSON B
JORKASKY D
Citation: D. Everitt et al., SAFETY, PHARMACOKINETICS, ANTIGENICITY AND FUSION INHIBITION-ACTIVITYOF SB-209763, A RESHAPED HUMAN MONOCLONAL-ANTIBODY TO RESPIRATORY SYNCYTIAL VIRUS, Pediatric research, 37(4), 1995, pp. 173-173
Authors:
ILSON B
BOIKE S
LAROUCHE J
FREED M
JORKASKY D
Citation: B. Ilson et al., THE ANGIOTENSIN-II RECEPTOR ANTAGONIST SB203220 DOES NOT INCREASE URIC-ACID (UA) EXCRETION IN HEALTHY-MEN, Journal of the American Society of Nephrology, 5(3), 1994, pp. 562-562
Authors:
EVERITT DE
BOIKE S
DAVIES B
ZARIFFA N
AUDET P
BROWN L
FREED M
ILSON B
ESSER K
BARTUS JO
SLACK G
SMITH G
JORKASKY D
Citation: De. Everitt et al., PHARMACOKINETICS, TOLERABILITY AND TNF INHIBITORY ACTIVITY OF 1,3-DI(CYCLOPROPYLMETHYL)-8-AMINOXANTHINE (BRL61063), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 150-150
Authors:
ILSON B
TENERO D
KNOX S
BOIKE S
AUDET P
FREED M
EVERITT D
BROWN L
BOYLE D
JORKASKY D
Citation: B. Ilson et al., FOOD SIGNIFICANTLY INCREASES THE ORAL BIOAVAILABILITY OF SK-AND-F, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 168-168
Authors:
BROCKS D
EVERITT D
BOIKE S
SMITH G
ZARIFFA N
BROWN L
AUDET P
JORKASKY D
ILSON B
FREED M
DAVIES B
Citation: D. Brocks et al., INFLUENCE OF FOOD ON THE PHARMACOKINETICS OF BRL-61063 IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 199-199
Authors:
ILSON B
BOIKE S
AUDET P
FREED M
EVERITT D
BROWN L
ZARIFFA N
JORKASKY D
Citation: B. Ilson et al., RENAL HEMODYNAMIC-EFFECTS OF SK-AND-F-108566 - A NONPEPTIDE SELECTIVEANGIOTENSIN (AII) RECEPTOR ATI ANTAGONIST, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 206-206
Authors:
PILTZ JR
STONE RA
AUDET P
BOIKE S
EVERITT D
SHUSTERMAN NH
JORKASKY D
Citation: Jr. Piltz et al., FENOLDOPAM, A SELECTIVE DOPAMINE-1 RECEPTOR AGONIST, RAISES INTRAOCULAR-PRESSURE IN MAN, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1121-1121
Risultati:
1-16
|